Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. Journal of Pathology 184(4): 396-400, 1998
Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. Journal of Pathology 198(4): 458-467, 2002
Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. Archives of Pathology and Laboratory Medicine 140(7): 686-689, 2017
Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management. Molecular Medicine Reports 2(6): 923-929, 2009
Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: An immunohistochemical study. Pathology International 50(7): 527-530, 2000
Expression of cyclins in ductal hyperplasia, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Yonsei Medical Journal 41(3): 345-353, 2000
Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy. Applied Spectroscopy 71(2): 300-307, 2018
Cyclin D1 expression in usual hyperplasia, atypical ductal hyperplasia and low nuclear grade ductal carcinoma in situ of the breast An immunohistochemical study. Journal of Pathology 187(Suppl. ): 25A, 1999
Clinical, radiographic, and pathologic correlation of atypical hyperplasia, ductal carcinoma in situ, and ductal carcinoma in situ with micro-invasion. Breast 2(1): 21-26, 1993
Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation. Virchows Archiv 439(1): 70-77, 2001
Comparison of rate limiting factors in the transformation of atypical ductal hyperplasia and ductal carcinoma in situ of the breast using immunohistochemistry and fluorescence in situ hybridization. Modern Pathology 16(1): 50A, 2003
Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion. Human Pathology 32(8): 785-790, 2001
TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment 41(2): 103-109, 1996
CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia. Breast Cancer Research and Treatment 84(3): 247-250, 2004
Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia. American Surgeon 77(9): 1272-1273, 2011